HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preston Dunnmon Selected Research

Immunoglobulin Light-chain Amyloidosis

1/2022Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Preston Dunnmon Research Topics

Disease

2Heart Failure
01/2016 - 04/2014
1Amyloidosis
01/2022
1Paraproteinemias (Monoclonal Gammopathy)
01/2022
1Immunoglobulin Light-chain Amyloidosis
01/2022
1Hypotension (Low Blood Pressure)
01/2016
1Ulcerative Colitis
04/2010

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
01/2022 - 01/2016
1Amyloid (Amyloid Fibrils)IBA
01/2022
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2022
1Sulfasalazine (Azulfidine)FDA LinkGeneric
04/2010
1SulfapyridineFDA Link
04/2010
1Mesalamine (Mesalazine)FDA LinkGeneric
04/2010

Therapy/Procedure

3Therapeutics
01/2022 - 04/2014
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2022